Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide-Reference-Cited by-同舟云学术

Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide

Published:1990-01 Issue:1 Volume:32 Page:71-74
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Skórski Tomasz,Kawalec Maciej,Kawiak Jerzy

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF01741728.pdf

Reference31 articles.

1. Appelbaum FR, Buckner CD (1986) Overview of the clinical relevance of autologous bone marrow transplantation. Clin Haematol 15: 1

2. Ashman LK, O'Keefe DE, Juttner CA, Toogood IRG, Rice MS (1986) Autologous responses to human leukaemic cells in mixed leukocyte culture. Cancer Immunol Immunother 22: 95

3. Butturini A, Gale RP (1989) How we can cure leukaemia? Br J Haematol 72: 479

4. Dennis JW, Laferte S, Man MS, Elliott BE, Kerbel RS (1984) Adoptive immune therapy in mice bearing poorly immunogenic metastases using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines. Int J Cancer 34: 709

5. Evans R, Duffy TM (1987) The inability of adodptive immunotherapy to eradicate tumour cells in radiation-induced chimeric mice: the possible down-regulation of intratumour immune amplification. Int J Cancer 39: 226

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer immunotherapy: insights from transgenic animal models;Critical Reviews in Oncology/Hematology;2001-10

2. Transfusion of donor peripheral blood buffy coat cells as effective treatment for relapsed acute leukemia after transplantation of allogeneic bone marrow or peripheral blood stem cells from the same donor;Transfusion;1996-08

3. Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells;Medical Oncology;1994-09

4. Pharmacological bone marrow purging in autologous transplantation: focus on the cyclophosphamide derivatives;Critical Reviews in Oncology/Hematology;1993-02

5. Interleukin-2 in the Treatment of Acute Myelocytic Leukemias: In Vitro Data and Presentation of a Clinical Concept;Acute Leukemias;1992